Inter-subject Variability
Inter-subject Variability - Related Videos
07:48
Within-subjects Repeated-measures Design
0 Views •
2023
Source: Laboratories of Gary Lewandowski, Dave Strohmetz, and Natalie Ciarocco—Monmouth University A within-subjects, or repeated-measures, design is an experimental design where all the participants receive every level of the treatment, i.e., every independent variable. For example, in a candy taste test, the researcher would want every participant to taste and rate each type of candy. This video demonstrates a within-subjects experiment (i.e., one where there is an independent variable with...
08:36
Dynamic Inter-subject Functional Connectivity Reveals Moment-to-Moment Brain Network Configurations Driven by Continuous or Communication Paradigms
0 Views •
Cited by 12 •
2019
The goal of the described approach is to determine at what moments of the paradigm (temporal perspective), and between which regions (spatial perspective), significant reconfigurations in functional connectivity occur on functional magnetic resonance imaging recordings during which a time-locked stimulus is played.
13:04
Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
0 Views •
Cited by 19 •
2012
Using functional MRI and behavioral methods to determine the neural representation of the subjective value of risky and ambiguous options in the human brain.
13:21
Determining heat and mechanical pain threshold in inflamed skin of human subjects
0 Views •
Cited by 21 •
2009
Algorithms assessing heat and mechanical pain thresholds in experimentally inflamed skin of human study subjects are shown. The two pain testing paradigms independently examine nociceptive processing by the two major peripheral nerve fiber populations transmitting pain, i.e., non-myelinated C fibers and small myelinated A-delta fibers.
01:13
Cable Subjected to Its Own Weight
0 Views •
2023
Overhead power transmission lines rely on cables to carry electricity across large distances. To ensure the stability and functionality of these lines, it is crucial to understand the shape and tension experienced by the cables under the influence of their weight. A generalized loading function is employed to analyze a cable subjected to its own weight. This function considers the force acting along the cable's arc length rather than its projected length, providing a more accurate...
FAQs
These factors can alter how an individual processes and responds to an intervention. Genetic differences may influence biological pathways, while age and physiology can change pharmacokinetics, the movement of a treatment through the body, and pharmacodynamics, the resulting biological effects. Consequently, participants receiving the same intervention may show different exposure levels, responses, or clinical outcomes.
Separating differences between participants from changes occurring within one participant over time prevents unlike sources of variation from being interpreted as the same effect. This distinction helps researchers determine whether an observed outcome reflects genuine differences among individuals or a time-related change within a person. The resulting interpretation is more useful for evaluating treatment effects and clinical outcomes.
Comorbidities, lifestyle factors, and environmental exposures add biological differences that may modify treatment behavior or clinical response. Their effects can contribute to variation in pharmacokinetics, pharmacodynamics, and disease characteristics across participants. Considering these factors helps explain why a treatment may provide different benefits or risks among individuals and supports more appropriate interpretation of clinical research findings.
A dose that produces an acceptable response in one participant may not produce the same exposure or effect in another. Differences among individuals can therefore affect both benefit and risk. Accounting for this variability during dose selection helps researchers avoid treating an average response as universally representative and provides a stronger basis for evaluating whether a regimen is suitable across the studied population.
Researchers quantify it by comparing biological measurements, disease characteristics, treatment responses, or clinical outcomes across participants. They also separate these between-person differences from changes measured repeatedly within the same individual. This analysis clarifies the extent of variation present in the study population and helps connect observed differences with factors such as genetics, age, physiology, comorbidities, lifestyle, or environment.
Clinical trials should interpret participant data with attention to the biological and clinical factors that may produce different responses. Comparing individuals while distinguishing within-person changes allows investigators to evaluate whether an outcome is consistent across the study population or varies substantially. This approach improves trial interpretation and informs dose selection, risk-benefit assessment, and later clinical use.
It becomes especially relevant when the same treatment produces meaningfully different responses, risks, or outcomes among individuals. Characterizing those differences provides evidence for moving beyond a single average response and toward treatment decisions informed by patient characteristics. In this way, inter-subject variability supports individualized treatment and provides a foundation for precision medicine in clinical care.
Analysis can inform how researchers interpret treatment benefits and risks, choose doses, and evaluate whether findings apply broadly across participants. It also helps clarify why disease characteristics or outcomes differ between individuals receiving similar care. These insights strengthen clinical research conclusions and support decisions that account for patient-level differences rather than relying only on population averages.